Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Webinar-HRD-Testing-1000x250

ESMO Webinar: The role of HRD testing in cancer

Chair: Rowan Miller
Speakers: James Brenton, Violeta Serra, Wassim Abida

Learning objectives

  • To understand the role of HRD testing in cancer
  • To understand different methods for HRD testing
  • To understand the clinical aspects of HRD as a predictive/prognostic biomarker in ovarian cancer
  • To understand the role of HRD testing beyond ovarian cancer

This webinar aims to review and discuss different methods for HRD testing, the clinical aspects of HRD as a predictive/prognostic biomarker in ovarian cancer and to understand the role of HRD testing in other tumour types.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.